எரிகா பீோறிணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from எரிகா பீோறிணி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In எரிகா பீோறிணி Today - Breaking & Trending Today
(0) DGAP-News: AFFiRiS AG / Key word(s): Conference/Study AFFiRiS AG: Positive preclinical in vivo results with AFFiRiS antibody mAB C6-17 to treat Huntington s disease to be presented at the 16th Annual Huntington s Disease Therapeutics Conference 27.04.2021 / 09:00 Positive preclinical in vivo results with AFFiRiS antibody mAB C6-17 to treat Huntington s disease to be presented at the 16 th Annual Huntington s Disease Therapeutics Conference - Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of Huntington s disease pathology - Human mtHTT transgenic mice treated with mAB C6-17 showed significantly reduced mtHTT levels in peripheral organs and central nervous system and displayed improved motor performance ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17 to treat Huntington’s . AFFiRiS AGApril 27, 2021 GMT Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of Huntington’s disease pathology Human mtHTT transgenic mice treated with mAB C6-17 showed significantly reduced mtHTT levels in peripheral organs and central nervous system and displayed improved motor performance Results set the ground for AFFiRiS’ potential first-in-class antibody-based systemic therapeutic modalities targeting mtHTT directly VIENNA, Austria, April 27, 2021 (GLOBE NEWSWIRE) AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific immunotherapies, announces today the presentation of ....
DGAP-News: AFFiRiS AG: Positive preclinical in vivo results with AFFiRiS' antibody mAB C6-17 to treat Huntington's disease to be presented at the 16th Annual Huntington's Disease Therapeutics Conference boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.